| Chronic Obstructive Pulmonary Disease |
1 |
1 |
| Clinical Guidelines |
0 |
0.7 |
| Bronchodilator |
0 |
0.35 |
| Dyspnea |
0 |
0.29 |
| Lung |
0 |
0.29 |
| Exercise |
0 |
0.23 |
| Vaccines |
0 |
0.23 |
| COVID-19 Vaccine |
0 |
0.2 |
| Influenza |
0 |
0.19 |
| Pneumonia |
0 |
0.19 |
| Pulmonary Rehabilitation |
0 |
0.17 |
| Smoking |
0 |
0.17 |
| Tobacco Cessation |
0 |
0.14 |
| Pulmonary Arterial Hypertension |
0 |
0.13 |
| Acidosis |
0 |
0.12 |
| Corticosteroids |
0 |
0.12 |
| Inhaled Corticosteroid |
0 |
0.12 |
| Jobs |
0 |
0.12 |
| Primary Pulmonary Hypertension |
0 |
0.12 |
| Pulmonary Function Test |
0 |
0.12 |
| Pulmonary Hypertension |
0 |
0.12 |
| Respiratory Acidosis |
0 |
0.12 |
| Antibiotics |
0 |
0.11 |
| Heart Failure (HF) |
0 |
0.11 |
| Physical Medicine and Rehabilitation (PMR) |
0 |
0.11 |
| Mechanical Ventilation |
0 |
0.1 |
| Asthma |
0 |
0.09 |
| Airway Inflammation |
0 |
0.08 |
| Arterial Blood Gases |
0 |
0.08 |
| Chronic Bronchitis |
0 |
0.08 |
| Hypertension |
0 |
0.08 |
| Adherence |
0 |
0.06 |
| Airway |
0 |
0.06 |
| Beta Blockers |
0 |
0.06 |
| Blood |
0 |
0.06 |
| Bronchitis |
0 |
0.06 |
| Disease Management |
0 |
0.8 |
| End-of-Life Care |
0 |
0.06 |
| Eosinophils |
0 |
0.06 |
| Glucocorticoid |
0 |
0.06 |
| Hemodynamics |
0 |
0.06 |
| Influenza Vaccine |
0 |
0.06 |
| Inhalers |
0 |
0.06 |
| Pneumococcal Vaccine |
0 |
0.06 |
| Primary Care |
0 |
0.06 |
| Tolerance |
0 |
0.06 |
| Viral Infection |
0 |
0.06 |
| COVID-19 |
0 |
0.04 |
| Opioids |
0 |
0.04 |
| Palliative Care |
0 |
0.04 |